<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>TB R&#38;D Matters Blog &#187; TB Treatment</title>
	<atom:link href="http://www.newtbdrugs.org/blog/category/tb-treatment/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.newtbdrugs.org/blog</link>
	<description>Working Towards a Faster Cure for Tuberculosis</description>
	<lastBuildDate>Sat, 19 May 2012 12:57:01 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
		<item>
		<title>TB R&amp;D Weekly Update:  Results from Preventative Therapy Trial in SA Miners</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-results-from-preventative-therapy-trial-in-sa-miners/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-results-from-preventative-therapy-trial-in-sa-miners/#comments</comments>
		<pubDate>Fri, 09 Mar 2012 16:54:53 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[aurum]]></category>
		<category><![CDATA[clinical trials]]></category>
		<category><![CDATA[croi]]></category>
		<category><![CDATA[isoniazid]]></category>
		<category><![CDATA[london school]]></category>
		<category><![CDATA[miners]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[preventative therapy]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3555</guid>
		<description><![CDATA[At the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, results on the Thibela TB preventative therapy trial in South Africa gold miners  was presented with mixed outcomes.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-results-from-preventative-therapy-trial-in-sa-miners/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Tailoring TB Treatment Based on Host Genotype?</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tailoring-treatment-based-on-host-genotype/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tailoring-treatment-based-on-host-genotype/#comments</comments>
		<pubDate>Fri, 03 Feb 2012 22:40:47 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[Life Cycle of Tuberculosis]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[animal models]]></category>
		<category><![CDATA[host-targeting]]></category>
		<category><![CDATA[innovations]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[targets]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[zebra fish]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3466</guid>
		<description><![CDATA[This week we have research out of the Ramakrishnan Laboratory that challenges thinking around tuberculosis treatment and considerations of host genotypes.  Additional links to TB R&#038;D news are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tailoring-treatment-based-on-host-genotype/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Totally Drug-Resistant TB</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-totally-drug-resistant-tb/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-totally-drug-resistant-tb/#comments</comments>
		<pubDate>Fri, 13 Jan 2012 21:09:41 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[crisis]]></category>
		<category><![CDATA[endemic]]></category>
		<category><![CDATA[india]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[totally drug resistant]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3394</guid>
		<description><![CDATA[Over the past couple of weeks there have been much discussion and reporting on totally drug-resistant tuberculosis (TDR-TB) based on reports of new cases in India.  Here are links to coverage of TDR-TB in India,  excerpt from a response by Dr. Nardell who we interviewed last year, and link to the WHO Fact Sheet on TDR-TB.  Additional links to TB R&#038;D News are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-totally-drug-resistant-tb/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Updated WHO guidelines on Drug-Resistant TB</title>
		<link>http://www.newtbdrugs.org/blog/updated-who-guidelines-on-drug-resistant-tb/</link>
		<comments>http://www.newtbdrugs.org/blog/updated-who-guidelines-on-drug-resistant-tb/#comments</comments>
		<pubDate>Thu, 11 Aug 2011 21:08:13 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Regulations and Guidelines]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3065</guid>
		<description><![CDATA[The WHO issued updated guidelines on the programmatic management of drug-resistant TB on August 4, 2011 online in the European Respiratory Journal.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/updated-who-guidelines-on-drug-resistant-tb/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Report:  The Millenium Development Goals 2011</title>
		<link>http://www.newtbdrugs.org/blog/report-the-millenium-development-goals-2011/</link>
		<comments>http://www.newtbdrugs.org/blog/report-the-millenium-development-goals-2011/#comments</comments>
		<pubDate>Thu, 04 Aug 2011 20:22:11 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[children]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[progress]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[report]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[UN]]></category>
		<category><![CDATA[United Nations]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=3040</guid>
		<description><![CDATA[The United Nations (UN) released a report on July 12 on the progress made thus far on the 8 Millennium Development Goals  (MDGs).  The eight MDGs include:  end poverty and hunger, universal education, gender equality, child health, maternal health, combat HIV/AIDS, environmental sustainability, and global partnership.  Key highlights and additional coverage on the report are included. ]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/report-the-millenium-development-goals-2011/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>News from the TB Treatment Field</title>
		<link>http://www.newtbdrugs.org/blog/news-from-the-field-of-tb-treatment/</link>
		<comments>http://www.newtbdrugs.org/blog/news-from-the-field-of-tb-treatment/#comments</comments>
		<pubDate>Wed, 27 Jul 2011 20:49:49 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Action]]></category>
		<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[australia]]></category>
		<category><![CDATA[community]]></category>
		<category><![CDATA[france]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[treatment]]></category>
		<category><![CDATA[usa]]></category>
		<category><![CDATA[WHO]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2997</guid>
		<description><![CDATA[Recent articles from around the globe related to governments addressing problems with providing treatment services to those with tuberculosis]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/news-from-the-field-of-tb-treatment/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Report:  An Evaluation of DR-TB Treatment Scale-up</title>
		<link>http://www.newtbdrugs.org/blog/report-an-evaluation-of-dr-tb-treatment-scale-up/</link>
		<comments>http://www.newtbdrugs.org/blog/report-an-evaluation-of-dr-tb-treatment-scale-up/#comments</comments>
		<pubDate>Thu, 14 Jul 2011 19:14:01 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Announcements]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[advocacy]]></category>
		<category><![CDATA[drug resistance]]></category>
		<category><![CDATA[evaluation]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[msf]]></category>
		<category><![CDATA[PIH]]></category>
		<category><![CDATA[press]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[scale-up]]></category>
		<category><![CDATA[TAG]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2943</guid>
		<description><![CDATA[MSF, PIH, and TAG release a report on MDR-TB scale up that shows poor progress that is leading to spread of MDR-TB and the continued loss of lives.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/report-an-evaluation-of-dr-tb-treatment-scale-up/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update: Latent TB Treatment in HIV and Children</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-latent-tb-treatment-in-hiv-and-children/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-latent-tb-treatment-in-hiv-and-children/#comments</comments>
		<pubDate>Thu, 07 Jul 2011 09:32:00 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB News]]></category>
		<category><![CDATA[TB Pediatrics]]></category>
		<category><![CDATA[TB Prevention and Control Strategies]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2918</guid>
		<description><![CDATA[In the July 7 issue of the New England Journal, two articles and an editorial on latent TB and TB prevention are published.  One study discusses positive results on a treatment for latent TB in HIV-infected persons.  The other study discusses negative findings that isoniazid is not effective in latent treatment of tuberculosis in children regardless of HIV status.  A link to MedPage Today is included that provides a good overview of these studies and the editorial. Additional TB R&#038;D News Links also are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-latent-tb-treatment-in-hiv-and-children/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Tuberculosis and Cancer</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tuberculosis-and-cancer/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tuberculosis-and-cancer/#comments</comments>
		<pubDate>Tue, 28 Jun 2011 21:59:01 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[TB Diagnostics]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[publications]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2886</guid>
		<description><![CDATA[This week we review a commentary on the correlations between tuberculosis and cancer, specifically lung cancer.  The article appeared in the June issue of Lancet Oncology.  Additional links to TB R&#038;D News are included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-tuberculosis-and-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TB R&amp;D Weekly Update:  Efflux and Rifampicin Resistance</title>
		<link>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-efflux-and-rifampicin-resistance/</link>
		<comments>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-efflux-and-rifampicin-resistance/#comments</comments>
		<pubDate>Tue, 14 Jun 2011 22:03:14 +0000</pubDate>
		<dc:creator>Working Group</dc:creator>
				<category><![CDATA[Early Drug Development]]></category>
		<category><![CDATA[Front Lines of TB R&D]]></category>
		<category><![CDATA[TB Drug Development]]></category>
		<category><![CDATA[TB Treatment]]></category>
		<category><![CDATA[diagnostics]]></category>
		<category><![CDATA[funding]]></category>
		<category><![CDATA[mdr]]></category>
		<category><![CDATA[r&d]]></category>
		<category><![CDATA[treatment]]></category>

		<guid isPermaLink="false">http://www.newtbdrugs.org/blog/?p=2796</guid>
		<description><![CDATA[This week we look again at the role of  efflux pumps in resistance to anti-tuberculosis drugs. Louw, et al., sought to "demonstrate that the level of rifampicin resistance is defined by efflux, which regulates the intracellular concentration of rifampicin."  This is a shift from the current thinking in the field that rifampicin resistance is solely the result of mutations in the rpoB gene.  The article entitled "Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin Resistant Mycobacterium tuberculosis through Efflux" was published ahead of print in the American Journal of Respiratory and Critical Care Medicine.  Additional links to TB R&#038;D News is included.]]></description>
		<wfw:commentRss>http://www.newtbdrugs.org/blog/tb-rd-weekly-update-efflux-and-rifampicin-resistance/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

